The Threat of Celexa Birth Defects and Possible Celexa Lawsuits
In recent reports, the consumer world has come to know more documentation pertaining to Celexa’s association with serious birth defects problems. Celexa is a medication categorized under serotonin reuptake inhibitors (SSRI), and is manufactured by Forest Laboratories. Scores of women of childbearing stage have been under antidepressant medications such as Celexa during pregnancy and were found to have their babies unknowingly exposed to congenital birth defects.
Antidepressant drugs, including Paxil, Prozac and Zoloft, have been found to have different side effects for the unborn child associated with them including the increased risk of premature birth, breathing problems, gastrointestinal side effects and motor problems. However, the specific level of risk of Celexa birth defects is, until now, unknown. Nonetheless, the development of complications was reported in babies associated with the medications. Expectant mothers take this drug during their pregnancy, and is said to expose their baby to the medication while in the womb resulting to the development of a Celexa birth defect.
Recorded Celexa birth defects include:
• PPHN (persistent pulmonary hypertension)
• Abdominal Birth Defects
• Heart Birth Defects
• Cranial Birth Defects
Triggered by compelling reports, the Food and Drug Administration released in 2004 a warning against the use of certain antidepressants for women during the late third trimester of their pregnancy to avoid the risk of birth defects. The warning advises that doctors may gradually taper pregnant women off antidepressant medications in the third trimester to avoid adversely affecting their babies. After delivery, a woman should consult with her doctor to determine whether it is right to return to full dose of the antidepressant medication during the time she is most vulnerable to conditions such as postpartum depression.
The Food and Drug Administration issued a safety alert in 2006 regarding the increased risk of persistent pulmonary hypertension (PPHN), a serious and life-threatening lung condition occurring soon after birth. The FDA alert covered SSRI drugs, including Celexa, together with other antidepressants.
Currently, in preparation to Celexa lawsuits, investigations are on-going on cases for families involving a Celexa birth defect that occurred after using this antidepressant drug. Individuals who feel affected by Celexa’s alleged risks must come out and raise their concern to let lawsuits on Celexa manufacturers progress.
Processing your request, Please wait....
